IRWD Crosses Above Average Analyst Target
November 10, 2016 at 10:29 AM EST
In recent trading, shares of Ironwood Pharmaceuticals Inc. (IRWD) have crossed above the average analyst 12-month target price of $15.38, changing hands for $16.13/share..
